Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

Jochem H. Bernink; Yoichiro Ohne; Marcel B. M. Teunissen; Jingya Wang; Jincheng Wu; Lisette Krabbendam; Christine Guntermann; Richard Volckmann; Jan Koster; Sophie van Tol; Ivan Ramirez; Yashaswi Shrestha; Menno A. de Rie; Hergen Spits; Xavier Romero Ros; Alison A. Humbles

doi:https://doi.org/10.1038/s41590-019-0554-3

Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

Jochem H. Bernink, Yoichiro Ohne, Marcel B. M. Teunissen, Jingya Wang, Jincheng Wu, Lisette Krabbendam, Christine Guntermann, Richard Volckmann, Jan Koster, Sophie van Tol, Ivan Ramirez, Yashaswi Shrestha, Menno A. de Rie, Hergen Spits, Xavier Romero Ros, Alison A. Humbles

Research output: Contribution to journal › Comment/Letter to the editor › Academic

1 Citation (Scopus)

Abstract

In the version of this article initially published, the cell conversion was stated incorrectly (‘ILC2s to ILC1-like cells’) in the first sentence of the second paragraph in the second Results subsection; the correct description is ‘ILC1s to ILC2-like cells’. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be ‘IL-13−APC’. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	101
Number of pages	1
Journal	Nature immunology
Volume	21
Issue number	1
DOIs	https://doi.org/10.1038/s41590-019-0554-3
Publication status	Published - 1 Jan 2020

Access to Document

https://doi.org/10.1038/s41590-019-0554-3

Cite this

Bernink, J. H., Ohne, Y., Teunissen, M. B. M., Wang, J., Wu, J., Krabbendam, L., Guntermann, C., Volckmann, R., Koster, J., van Tol, S., Ramirez, I., Shrestha, Y., de Rie, M. A., Spits, H., Ros, X. R., & Humbles, A. A. (2020). Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0). Nature immunology, 21(1), 101. https://doi.org/10.1038/s41590-019-0554-3

@article{aa5bc06c119344f88e74b80edbf2617a,

title = "Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)",

abstract = "In the version of this article initially published, the cell conversion was stated incorrectly ({\textquoteleft}ILC2s to ILC1-like cells{\textquoteright}) in the first sentence of the second paragraph in the second Results subsection; the correct description is {\textquoteleft}ILC1s to ILC2-like cells{\textquoteright}. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be {\textquoteleft}IL-13−APC{\textquoteright}. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.",

author = "Bernink, {Jochem H.} and Yoichiro Ohne and Teunissen, {Marcel B. M.} and Jingya Wang and Jincheng Wu and Lisette Krabbendam and Christine Guntermann and Richard Volckmann and Jan Koster and {van Tol}, Sophie and Ivan Ramirez and Yashaswi Shrestha and {de Rie}, {Menno A.} and Hergen Spits and Ros, {Xavier Romero} and Humbles, {Alison A.}",

year = "2020",

month = jan,

day = "1",

doi = "https://doi.org/10.1038/s41590-019-0554-3",

language = "English",

volume = "21",

pages = "101",

journal = "Nature Immunology",

issn = "1529-2908",

publisher = "Nature Publishing Group",

number = "1",

}

Bernink, JH, Ohne, Y, Teunissen, MBM, Wang, J, Wu, J, Krabbendam, L, Guntermann, C, Volckmann, R , Koster, J, van Tol, S, Ramirez, I, Shrestha, Y, de Rie, MA , Spits, H, Ros, XR & Humbles, AA 2020, 'Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)', Nature immunology, vol. 21, no. 1, pp. 101. https://doi.org/10.1038/s41590-019-0554-3

Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0). / Bernink, Jochem H.; Ohne, Yoichiro; Teunissen, Marcel B. M. et al.
In: Nature immunology, Vol. 21, No. 1, 01.01.2020, p. 101.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

AU - Bernink, Jochem H.

AU - Ohne, Yoichiro

AU - Teunissen, Marcel B. M.

AU - Wang, Jingya

AU - Wu, Jincheng

AU - Krabbendam, Lisette

AU - Guntermann, Christine

AU - Volckmann, Richard

AU - Koster, Jan

AU - van Tol, Sophie

AU - Ramirez, Ivan

AU - Shrestha, Yashaswi

AU - de Rie, Menno A.

AU - Spits, Hergen

AU - Ros, Xavier Romero

AU - Humbles, Alison A.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - In the version of this article initially published, the cell conversion was stated incorrectly (‘ILC2s to ILC1-like cells’) in the first sentence of the second paragraph in the second Results subsection; the correct description is ‘ILC1s to ILC2-like cells’. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be ‘IL-13−APC’. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.

AB - In the version of this article initially published, the cell conversion was stated incorrectly (‘ILC2s to ILC1-like cells’) in the first sentence of the second paragraph in the second Results subsection; the correct description is ‘ILC1s to ILC2-like cells’. Also, the far left plot in Fig. 1d was missing the vertical axis label; this should be ‘IL-13−APC’. Finally, in the legend to Fig. 3a,b, the human ILCs were identified incorrectly (CD45+CD56‒CD127‒); the correct phenotype is CD45+CD56‒CD127+. The errors have been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85077016980&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41590-019-0554-3

DO - https://doi.org/10.1038/s41590-019-0554-3

M3 - Comment/Letter to the editor

C2 - 31723260

SN - 1529-2908

VL - 21

SP - 101

JO - Nature Immunology

JF - Nature Immunology

IS - 1

ER -

Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

Abstract

Access to Document

Other files and links

Cite this